InoLife Technologies Introduces the Marketing of JuVesse as the First of Its Skin Care Line of Products

InoLife Technologies Introduces the Marketing of JuVesse as the First of Its
Skin Care Line of Products

Global Market for Skin Care Products Remains Robust, With North American and
EU Sales Projected to Reach $274 Billion by 2013

RALEIGH, N.C., Jan. 31, 2013 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc.
("InoLife") (OTCQB:INOLD), announces they will begin marketing the JuVesse
skin care product as the first of many new and exciting skin care products.

JuVesse is an age reversing product which is a chemical free formula for the
activation of endogenous "stem cells" in the skin and body, formulated
exclusively from all natural ingredients. The underlying science and
technology embodied in these products was the result of over two decades of
international and domestic research into the natural causes of aging, and how
to reverse the aging process. This breakthrough science has multiple
applications including creams and lotions for "anti-aging" or "age reverses"
stimulating follicle growth, facilitating skin repair and curing cystic
acne.The JuVesse cream for the face and body contain "anti-aging benefits" by
activating the body's own "stem cells" in the skin to increase the natural
substances which promote moisture and fullness in the skin, and activate each
cell to regenerate the tissue.This technology is actually using nature itself
to reverse its own natural aging processes.

"We feel the timing is great for the introduction of the JuVesse skin care
product.This is the first of many other exciting new skin care products.The
global market for skin care products remains robust, with North American and
EU sales projected to reach $274 Billion by 2013," said Gary Berthold, CEO of
InoLife."The "anti aging" segment of the skin care is burgeoning. This
explosive growth is being bolstered by the aging baby boomer population and
the increasing awareness about age prevention by younger consumers in the 25
to 30 year old age group."

About InoLife Technologies, Inc.

InoLife Technologies' mission is to aggressively identify, manufacture and
market innovative and affordable healthcare products and services directly to
the marketplace. InoLife Technologies, Inc. markets the commercial use of
proprietary Intellectual Property by manufacturing, brand marketing and
selling an integrated program of age reversing creams and lotions.

"Safe Harbor Statement"

InoLife Technologies, Inc. (OTCQB:INOLD), believes it is well prepared to
succeed in both its geographic and strategic focus areas based on the new
ideas and extensive experience of its management team. One of our most
important responsibilities is to communicate with shareholders in an open and
direct manner. Comments are based on current management expectations, and are
considered "forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We cannot promise
future returns. Our statements reflect our best judgment at the time they are
issued, and we disclaim any obligation to update or alter forward-looking
statements as the result of new information or future events. InoLife
Technologies, Inc. (OTCQB:INOLD), urges investors to review the risks and
uncertainties contained within its filings with the Securities and Exchange
Commission. For further company information, please visit

CONTACT: InoLife Technologies, Inc
         Investor Relations:
         William A. Young Sr. Ph: 623-238-5245
Press spacebar to pause and continue. Press esc to stop.